JP2016537010A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016537010A5 JP2016537010A5 JP2016540920A JP2016540920A JP2016537010A5 JP 2016537010 A5 JP2016537010 A5 JP 2016537010A5 JP 2016540920 A JP2016540920 A JP 2016540920A JP 2016540920 A JP2016540920 A JP 2016540920A JP 2016537010 A5 JP2016537010 A5 JP 2016537010A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- luminal
- breast cancer
- biological sample
- subtype
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361875373P | 2013-09-09 | 2013-09-09 | |
| US61/875,373 | 2013-09-09 | ||
| US201461990948P | 2014-05-09 | 2014-05-09 | |
| US61/990,948 | 2014-05-09 | ||
| PCT/US2014/054760 WO2015035377A1 (en) | 2013-09-09 | 2014-09-09 | Methods and kits for predicting outcome and methods and kits for treating breast cancer with radiation therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016537010A JP2016537010A (ja) | 2016-12-01 |
| JP2016537010A5 true JP2016537010A5 (https=) | 2017-09-14 |
Family
ID=51688397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016540920A Pending JP2016537010A (ja) | 2013-09-09 | 2014-09-09 | 予後を予測するための方法及びキット、並びに、放射線照射療法を用いた乳癌の治療方法及びキット |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20150072021A1 (https=) |
| EP (1) | EP3044332A1 (https=) |
| JP (1) | JP2016537010A (https=) |
| AU (1) | AU2014317843A1 (https=) |
| CA (1) | CA2923166A1 (https=) |
| IL (1) | IL244421A0 (https=) |
| WO (1) | WO2015035377A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030198972A1 (en) | 2001-12-21 | 2003-10-23 | Erlander Mark G. | Grading of breast cancer |
| DK2297359T3 (en) | 2008-05-30 | 2014-02-24 | Univ Utah Res Found | Gene expression profiles to predict the outcome of breast cancer |
| JP7144142B2 (ja) | 2014-11-24 | 2022-09-29 | ナノストリング テクノロジーズ，インコーポレイティド | 遺伝子精製および画像化のための方法および装置 |
| WO2016091880A1 (en) * | 2014-12-09 | 2016-06-16 | King's College London | Breast cancer treatment with taxane therapy |
| US11530448B2 (en) | 2015-11-13 | 2022-12-20 | Biotheranostics, Inc. | Integration of tumor characteristics with breast cancer index |
| EP3423105B1 (en) | 2016-03-02 | 2021-05-05 | Eisai R&D Management Co., Ltd. | Eribulin-based antibody-drug conjugates and methods of use |
| CN107574243B (zh) * | 2016-06-30 | 2021-06-29 | 博奥生物集团有限公司 | 分子标志物、内参基因及其应用、检测试剂盒以及检测模型的构建方法 |
| CN108456730B (zh) * | 2018-02-27 | 2021-01-05 | 海门善准生物科技有限公司 | 一种复发风险基因群作为标志物在制备评估乳腺癌分子分型内远处复发风险的产品中的应用 |
| WO2020206359A1 (en) * | 2019-04-04 | 2020-10-08 | University Of Utah Research Foundation | Multigene assay to assess risk of recurrence of cancer |
| KR102414754B1 (ko) * | 2019-10-10 | 2022-06-30 | 주식회사 종근당 | 직장암 항암화학방사선 치료 반응 예측용 바이오마커 |
| TW202129008A (zh) * | 2019-11-05 | 2021-08-01 | 香港商行動基因（智財）有限公司 | 檢測異檸檬酸脫氫酶突變的套組及方法 |
| EP3945136A1 (en) * | 2020-07-28 | 2022-02-02 | Hospital Clínic de Barcelona | In vitro method for the prognosis of patients suffering from her2-positive breast cancer |
| CN113278700B (zh) * | 2021-06-04 | 2022-08-09 | 浙江省肿瘤医院 | 一种用于乳腺癌分型及预后预测的引物组及试剂盒 |
| KR20240081508A (ko) | 2022-11-17 | 2024-06-10 | 인제대학교 산학협력단 | Dna 메틸화 변화를 통한 방사선치료 반응성 예측용 바이오마커 조성물 및 이의 용도 |
| CN116622885B (zh) * | 2023-05-23 | 2025-01-10 | 福建省农业科学院果树研究所 | 一种用于不同桃花色鉴定的分子标记方法及其应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4843155A (en) | 1987-11-19 | 1989-06-27 | Piotr Chomczynski | Product and process for isolating RNA |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| JP2001524926A (ja) | 1991-09-18 | 2001-12-04 | アフィマックス テクノロジーズ ナームロゼ フェンノートシャップ | オリゴマーの雑多ライブラリーの集合体を合成する方法 |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| DE69233501T2 (de) | 1991-11-22 | 2006-02-23 | Affymetrix, Inc. (n.d.Ges.d.Staates Delaware), Santa Clara | Kombinatorische Strategien für die Polymersynthese |
| US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
| US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| EP0880598A4 (en) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM |
| EP1027456B1 (en) | 1997-10-31 | 2005-03-16 | Affymetrix, Inc. (a Delaware Corporation) | Expression profiles in adult and fetal organs |
| US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
| US20080032293A1 (en) | 2004-07-15 | 2008-02-07 | The University Of North Carolina At Chapel Hill | Housekeeping Genes And Methods For Identifying Same |
| CA2630974A1 (en) | 2005-11-23 | 2007-05-31 | University Of Utah Research Foundation | Methods and compositions involving intrinsic genes |
| US8986926B2 (en) | 2005-12-23 | 2015-03-24 | Nanostring Technologies, Inc. | Compositions comprising oriented, immobilized macromolecules and methods for their preparation |
| EP1963531B1 (en) | 2005-12-23 | 2011-09-21 | Nanostring Technologies, Inc. | Nanoreporters and methods of manufacturing and use thereof |
| US7892740B2 (en) * | 2006-01-19 | 2011-02-22 | The University Of Chicago | Prognosis and therapy predictive markers and methods of use |
| US8415102B2 (en) | 2007-04-10 | 2013-04-09 | Nanostring Technologies, Inc. | Methods and computer systems for identifying target-specific sequences for use in nanoreporters |
| EP2195467B1 (en) * | 2007-09-06 | 2016-12-14 | bioTheranostics, Inc. | Tumor grading and cancer prognosis in breast cancer |
| CA2699376C (en) * | 2007-09-14 | 2018-10-23 | University Of South Florida | Gene signature for the prediction of radiation therapy response |
| DK2297359T3 (en) * | 2008-05-30 | 2014-02-24 | Univ Utah Res Found | Gene expression profiles to predict the outcome of breast cancer |
| US8519115B2 (en) | 2008-08-14 | 2013-08-27 | Nanostring Technologies, Inc. | Stable nanoreporters |
| AU2012345789B2 (en) * | 2011-11-30 | 2018-02-15 | British Columbia Cancer Agency Branch | Methods of treating breast cancer with taxane therapy |
| AU2013266419B2 (en) * | 2012-05-22 | 2018-09-27 | British Columbia Cancer Agency Branch | NANO46 genes and methods to predict breast cancer outcome |
-
2014
- 2014-09-09 EP EP14781977.5A patent/EP3044332A1/en not_active Withdrawn
- 2014-09-09 CA CA2923166A patent/CA2923166A1/en not_active Abandoned
- 2014-09-09 US US14/480,942 patent/US20150072021A1/en not_active Abandoned
- 2014-09-09 WO PCT/US2014/054760 patent/WO2015035377A1/en not_active Ceased
- 2014-09-09 JP JP2016540920A patent/JP2016537010A/ja active Pending
- 2014-09-09 AU AU2014317843A patent/AU2014317843A1/en not_active Abandoned
-
2016
- 2016-03-03 IL IL244421A patent/IL244421A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016537010A5 (https=) | ||
| JP2010538609A5 (https=) | ||
| ES2730384T3 (es) | Puntuación de la infiltración linfocitaria de los tumores | |
| ES2550192T3 (es) | Biomarcadores para el cáncer de pulmón | |
| Arnedos et al. | Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial | |
| Stav et al. | Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma | |
| Gerashchenko et al. | Intratumoral morphological heterogeneity of breast cancer as an indicator of the metastatic potential and tumor chemosensitivity | |
| JP2017503481A5 (https=) | ||
| CN106148529B (zh) | 与胃癌相关的LncRNA标记物及其专用检测引物、检测方法、试剂盒与应用 | |
| JP2018527886A5 (https=) | ||
| Sakabe et al. | Expression of cancer stem cell-associated DKK1 mRNA serves as prognostic marker for hepatocellular carcinoma | |
| JP2015210268A5 (https=) | ||
| EP2390370A3 (en) | A method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent | |
| ES2874398T3 (es) | miARN circulantes como marcador de detección temprana y marcador pronóstico | |
| US20120244531A1 (en) | Method for providing information for diagnosing cancer using quantitative real-time pcr and kit for diagnosing cancer for the same | |
| JP2017516501A5 (https=) | ||
| JP2013532489A (ja) | 遺伝子発現プロファイリングに基づくがん治療への応答の予測ならびにモニタリング | |
| JP2011527575A5 (https=) | ||
| Donnem et al. | Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer | |
| Kim et al. | DICER1 exons 25 and 26 mutations are rare in common human tumours besides Sertoli-Leydig cell tumour. | |
| Vishnukumar et al. | P-glycoprotein expression as a predictor of response to neoadjuvant chemotherapy in breast cancer | |
| Li et al. | Increased expression of long noncoding RNA AK021443 predicts worse clinical outcome in hepatocellular carcinoma | |
| Davidson et al. | Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion | |
| Zhou et al. | Increased expression of long non-coding RNA SBDSP1 correlates with poor survival in colorectal cancer | |
| WO2018165532A1 (en) | Methods for diagnosing and treating gastric cancer using mirna expression |